Sensitive bioassay for detection of PPARα potentially hazardous ligands with gold nanoparticle probe

Journal of Hazardous Materials

Volumn 192, Issue 3, 2011, Pages 1148-1154

  Xia, Wei ^a   Wan, Yan Jian ^b   Wang, Xianliang ^a   Li, Yuan yuan ^a   Yang, Wen Jie ^a   Wang, Chun Xiang ^a   Xu, Shun qing ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b CHINESE RESEARCH ACADEMY OF ENVIRONMENTAL SCIENCES   (China)

Author keywords

Bioassay; Gold nanoparticle; PFOS; PPAR

Indexed keywords

DETECTION LIMITS; GOLD NANOPARTICLE; GOLD NANOPARTICLES; HAZARDOUS EFFECTS; HETERODIMERS; HIGH SENSITIVITY; HIGH-THROUGHPUT DETECTION; HUMAN HEALTH; LIGAND-RECEPTOR INTERACTIONS; LINEAR RANGE; MICROPLATES; MONO-(2-ETHYLHEXYL)PHTHALATE; NANOPARTICLE PROBES; PERFLUOROOCTANE SULFONATES; PERFLUOROOCTANOIC ACID; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; PFOS; PRESCREENING; RETINOID X RECEPTOR; SILVER ENHANCEMENT; SPIKED SAMPLES; TANDEM-MASS SPECTROMETRY; WIDE-LINEAR RANGE;

BIOASSAY; COMPLEXATION; CYTOLOGY; GOLD; HERBICIDES; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NANOPARTICLES; PLASTICIZERS; PROBES; SOLVENTS;

LIGANDS;

GOLD NANOPARTICLE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; RETINOID X RECEPTOR ALPHA;

ANTIBODY; BIOASSAY; DRUG; GOLD; HERBICIDE; LIGAND; MASS SPECTROMETRY; OPTICAL PROPERTY; PLASTIC; POLLUTION EFFECT; PROBE; PUBLIC HEALTH; SENSITIVITY ANALYSIS; TOXICITY;

ANIMAL TISSUE; ARTICLE; BIOASSAY; CHEMICAL INTERACTION; CONTROLLED STUDY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; OPTICAL DENSITY; WATER ANALYSIS; WATER POLLUTION CONTROL;

ALKANESULFONIC ACIDS; ANIMALS; BIOLOGICAL ASSAY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIETHYLHEXYL PHTHALATE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL MONITORING; FLUOROCARBONS; GOLD; HUMANS; LIGANDS; LIVER; MALE; METAL NANOPARTICLES; NANOTECHNOLOGY; OCTANOIC ACIDS; OLIGONUCLEOTIDES; PPAR ALPHA; RATS; RATS, SPRAGUE-DAWLEY; WATER PURIFICATION;

EID: 80052022143     PISSN: 03043894     EISSN: 18733336     Source Type: Journal    
DOI: 10.1016/j.jhazmat.2011.06.023     Document Type: Article

References (43)

1. Shipley J.M., Hurst C.H., Tanaka S.S., DeRoos F.L., Butenhoff J.L., Seacat A.M., Waxman D.J. Trans-activation of PPARalpha and induction of PPARalpha target genes by perfluorooctane-based chemicals. Toxicol. Sci. 2004, 80:151-160.
2. Hurst C.H., Waxman D.J. Activation of PPARalpha and PPARgamma by environmental phthalate monoesters. Toxicol. Sci. 2003, 74:297-308.
3. Ericson I., Nadal M., van Bavel B., Lindstrom G., Domingo J.L. Levels of perfluorochemicals in water samples from Catalonia, Spain: is drinking water a significant contribution to human exposure?. Environ. Sci. Pollut. Res. Int. 2008, 15:614-619.
4. Kannan K., Corsolini S., Falandysz J., Fillmann G., Kumar K.S., Loganathan B.G., Mohd M.A., Olivero J., Van Wouwe N., Yang J.H., Aldoust K.M. Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries. Environ. Sci. Technol. 2004, 38:4489-4495.
5. Giesy J.P., Kannan K. Global distribution of perfluorooctane sulfonate in wildlife. Environ. Sci. Technol. 2001, 35:1339-1342.
6. Nakayama S., Harada K., Inoue K., Sasaki K., Seery B., Saito N., Koizumi A. Distributions of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) in Japan and their toxicities. Environ. Sci. 2005, 12:293-313.
7. Johansson N., Fredriksson A., Eriksson P. Neonatal exposure to perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) causes neurobehavioural defects in adult mice. Neurotoxicology 2008, 29:160-169.
8. Hansen K.J., Clemen L.A., Ellefson M.E., Johnson H.O. Compound-specific, quantitative characterization of organic fluorochemicals in biological matrices. Environ. Sci. Technol. 2001, 35:766-770.
9. Saez M., de Voogt P., Parsons J.R. Persistence of perfluoroalkylated substances in closed bottle tests with municipal sewage sludge. Environ. Sci. Pollut. Res. Int. 2008, 15:472-477.
10. Scott B.F., Moody C.A., Spencer C., Small J.M., Muir D.C., Mabury S.A. Analysis for perfluorocarboxylic acids/anions in surface waters and precipitation using GC-MS and analysis of PFOA from large-volume samples. Environ. Sci. Technol. 2006, 40:6405-6410.
11. Enevoldsen R., Juhler R.K. Perfluorinated compounds (PFCs) in groundwater and aqueous soil extracts: using inline SPE-LC-MS/MS for screening and sorption characterisation of perfluorooctane sulphonate and related compounds. Anal. Bioanal. Chem. 2010, 398:1161-1172.
12. Zhao X., Li J., Shi Y., Cai Y., Mou S., Jiang G. Determination of perfluorinated compounds in wastewater and river water samples by mixed hemimicelle-based solid-phase extraction before liquid chromatography-electrospray tandem mass spectrometry detection. J. Chromatogr. A 2007, 1154:52-59.
13. Lein N.P.H., Fujii S., Tanaka S., Nozoe M., Tanaka H. Contamination of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in surface water of the Yodo River basin (Japan). Desalination 2008, 226:338-347.
14. Cheng J., Vecitis C.D., Park H., Mader B.T., Hoffmann M.R. Sonochemical degradation of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in landfill groundwater: environmental matrix effects. Environ. Sci. Technol. 2008, 42:8057-8063.
15. Kim H.S., Han S.-Y., Yoo S.D., Lee B.M., Park K.L. Potential estrogenic effects of bisphenol A estimated by in vitro and vivo combination assays. J. Toxicol. Sci. 2001, 26:112-118.
16. Juge-Aubry C., Pernin A., Favez T., Burger A.G., Wahli W., Meier C.A., Desvergne B. DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 5′-flanking region. J. Biol. Chem. 1997, 272:25252-25259.
17. Klaunig J.E., Babich M.A., Baetcke K.P., Cook J.C., Corton J.C., David R.M., DeLuca J.G., Lai D.Y., McKee R.H., Peters J.M., Roberts R.A., Fenner-Crisp P.A. PPARalpha agonist-induced rodent tumors: modes of action and human relevance. Crit. Rev. Toxicol. 2003, 33:655-780.
18. Myers K.A., Lambe K.G., Aldridge T.C., Macdonald N., Tugwood J.D. Amino acid residues in both the DNA-binding and ligand-binding domains influence transcriptional activity of the human peroxisome proliferator-activated receptor alpha. Biochem. Biophys. Res. Commun. 1997, 239:522-526.
19. Shearer B.G., Hoekstra W.J. Recent advances in peroxisome proliferator-activated receptor science. Curr. Med. Chem. 2003, 10:267-280.
20. Baptista P.V., Koziol-Montewka M., Paluch-Oles J., Doria G., Franco R. Gold-nanoparticle-probe-based assay for rapid and direct detection of Mycobacterium tuberculosis DNA in clinical samples. Clin. Chem. 2006, 52:1433-1434.
21. Huber M., Wei T.F., Muller U.R., Lefebvre P.A., Marla S.S., Bao Y.P. Gold nanoparticle probe-based gene expression analysis with unamplified total human RNA. Nucleic Acids Res. 2004, 32:e137.
22. Wang Z., Lee J., Cossins A.R., Brust M. Microarray-based detection of protein binding and functionality by gold nanoparticle probes. Anal. Chem. 2005, 77:5770-5774.
23. Li Y.Y., Zhang C., Li B.S., Zhao L.F., Li X.B., Yang W.J., Xu S.Q. Ultrasensitive densitometry detection of cytokines with nanoparticle-modified aptamers. Clin. Chem. 2007, 53:1061-1066.
24. Hill H.D., Vega R.A., Mirkin C.A. Nonenzymatic detection of bacterial genomic DNA using the bio bar code assay. Anal. Chem. 2007, 79:9218-9223.
25. Zheng G., Daniel W.L., Mirkin C.A. A new approach to amplified telomerase detection with polyvalent oligonucleotide nanoparticle conjugates. J. Am. Chem. Soc. 2008, 130:9644-9645.
26. Medley C.D., Smith J.E., Tang Z., Wu Y., Bamrungsap S., Tan W. Gold nanoparticle-based colorimetric assay for the direct detection of cancerous cells. Anal. Chem. 2008, 80:1067-1072.
27. Frederiksen K.S., Wulff E.M., Sauerberg P., Mogensen J.P., Jeppesen L., Fleckner J. Prediction of PPAR-alpha ligand-mediated physiological changes using gene expression profiles. J. Lipid Res. 2004, 45:592-601.
28. Braissant O., Foufelle F., Scotto C., Dauca M., Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 1996, 137:354-366.
29. Crinelli R., Bianchi M., Gentilini L., Magnani M. Design and characterization of decoy oligonucleotides containing locked nucleic acids. Nucleic Acids Res. 2002, 30:2435-2443.
30. Li B.S., Zhao L.F., Zhang C., Hei X.H., Li F., Li X.B., Shen J., Li Y.Y., Huang Q., Xu S.Q. Ultra-sensitive colorimetric method to quantitate hundreds of polynucleotide molecules by gold nanoparticles with silver enhancement. Anal. Sci. 2006, 22:1367-1370.
31. Wang L.H., Yang X.Y., Zhang X., Mihalic K., Xiao W., Farrar W.L. The cis decoy against the estrogen response element suppresses breast cancer cells via target disrupting c-fos not mitogen-activated protein kinase activity. Cancer Res. 2003, 63:2046-2051.
32. Jie G.J., Liu B., Pan H.C., Zhu J., Chen H.Y. CdS nanocrystal-based electrochemiluminescence biosensor for the detection of low-density lipoprotein by increasing sensitivity with gold nanoparticle amplification. Anal. Chem. 2007, 79:5574-5581.
33. Spink D.C., Katz B.H., Hussain M.M., Pentecost B.T., Cao Z., Spink B.C. Estrogen regulates Ah responsiveness in MCF-7 breast cancer cells. Carcinogenesis 2003, 24:1941-1950.
34. Hill H.D., Mirkin C.A. The bio-barcode assay for the detection of protein and nucleic acid targets using DTT-induced ligand exchange. Nat. Protoc. 2006, 1:324-336.
35. Orchard K., May G.E. An EMSA-based method for determining the molecular weight of a protein-DNA complex. Nucleic Acids Res. 1993, 21:3335-3336.
36. Larouche K., Bergeron M.J., Leclerc S., Guerin S.L. Optimization of competitor poly(dI-dC).poly(dI-dC) levels is advised in DNA-protein interaction studies involving enriched nuclear proteins. Biotechniques 1996, 20:439-444.
37. Li Z., Jin R., Mirkin C.A., Letsinger R.L. Multiple thiol-anchor capped DNA-gold nanoparticle conjugates. Nucleic Acids Res. 2002, 30:1558-1562.
38. Takacs M.L., Abbott B.D. Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate. Toxicol. Sci. 2007, 95:108-117.
39. Lovekamp-Swan T., Jetten A.M., Davis B.J. Dual activation of PPARalpha and PPARgamma by mono-(2-ethylhexyl) phthalate in rat ovarian granulosa cells. Mol. Cell. Endocrinol. 2003, 201:133-141.
40. Murk A.J., Legler J., Denison M.S., Giesy J.P., van de Guchte C., Brouwer A. Chemical-activated luciferase gene expression (CALUX): a novel in vitro bioassay for Ah receptor active compounds in sediments and pore water. Fundam. Appl. Toxicol. 1996, 33:149-160.
41. Sun X., Li F., Wang Y.J., Li Y.R., Su Y.H., Li Y.Y., Yan H., Xu S.Q. Development of an exonuclease protection mediated PCR bioassay for sensitive detection of Ah receptor agonists. Toxicol. Sci. 2004, 80:49-53.
42. Bossi J.S.R., Sortkjær O., Larsen M.M. Perfluoroalkyl compounds in Danish wastewater treatment plants and aquatic environments. Environ. Int. 2008, 34:443-450.
43. Jin Y.H., Liu W., Sato I., Nakayama S.F., Sasaki K., Saito N., Tsuda S. PFOS and PFOA in environmental and tap water in China. Chemosphere 2009, 77:605-611.